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In the principal neurons of striatum (medium spiny neurons, MSNs), cAMP pathway is
primarily activated through the stimulation of dopamine D1 and adenosine A2A recep-
tors, these receptors being mainly expressed in striatonigral and striatopallidal MSNs,
respectively. Since cAMP signaling pathway could be altered in various physiological and
pathological circumstances, including drug addiction and Parkinson’s disease, it is of crucial
importance to identify the molecular components involved in the activation of this path-
way. In MSNs, cAMP pathway activation is not dependent on the classical Gs GTP-binding
protein but requires a speciﬁc G protein subunit heterotrimer containing Gαolf/β2/γ7 in
particular association with adenylyl cyclase type 5.This assembly forms an authentic func-
tional signaling unit since loss of one of its members leads to defects of cAMP pathway
activation in response to D1 or A2A receptor stimulation, inducing dramatic impairments
of behavioral responses dependent on these receptors. Interestingly, D1 receptor (D1R)-
dependent cAMP signaling is modulated by the neuronal levels of Gαolf, indicating that
Gαolf represents the rate-limiting step in this signaling cascade and could constitute a
critical element for regulation of D1R responses. In both Parkinsonian patients and sev-
eral animal models of Parkinson’s disease, the lesion of dopamine neurons produces a
prolonged elevation of Gαolf levels. This observation gives an explanation for the cAMP
pathway hypersensitivity to D1R stimulation, occurring despite an unaltered D1R density.
In conclusion, alterations in the highly specialized assembly of Gαolf/β2/γ7 subunits can
happen in pathological conditions, such as Parkinson’s disease, and it could have important
functional consequences in relation to changes in D1R signaling in the striatum.
Keywords: D1 receptor,A2A receptor, heterotrimeric G protein, cAMP pathway, extracellular signal-regulated kinase,
Gnal gene, Parkinson’s disease, cocaine
INTRODUCTION
Dopamine, probably the best characterized neurotransmitter
involved in slow synaptic neurotransmission, plays a prominent
role in a variety of brain functions, including motor control,moti-
vation, short-termmemory, and reward (Schultz, 1998). Five genes
encoding dopamine receptors have been cloned in mammals (see
Sibley and Monsma, 1992 for review). All these receptors belong
to the superfamily of G protein-coupled receptors with seven
transmembrane domains and the comparison of their amino acid
sequence, pharmacological proﬁle, and biochemical properties has
revealed two distinct categories, named respectively D1- and D2-
type dopamine receptors. The D1-type receptors, comprising D1
and D5 subtypes, are positively coupled to cAMP production
whereas the D2-type receptors, comprising D2, D3, and D4 sub-
types, are able to inhibit cAMP production (see Missale et al., 1998
review). The D1 receptor (D1R) is the most abundantly expressed
dopamine receptors and is present in virtually all the brain areas
innervated by dopamine neurons (Boyson et al., 1986). Consistent
with its dense dopamine innervation, the striatum contains the
highest concentration of D1Rs in the brain. Different approaches
using in situ hybridization, immunocytochemistry, and transgenic
mice indicate that D1R in the striatum is highly expressed in a
subpopulation of GABAergicmedium spiny neurons (MSNs) pro-
jecting to the substantia nigra and entopeduncular nucleus (direct
pathway of basal ganglia) and containing substance P and dynor-
phin as co-neurotransmitters (Gerfen et al., 1990; Le Moine and
Bloch, 1995; Yung et al., 1995; Drago et al., 1998b; Gong et al.,
2003; Lee et al., 2006; Bertran-Gonzalez et al., 2008). By contrast,
D2 receptors are essentially present in the MSNs projecting to the
globus pallidus and containing enkephalins (indirect pathway of
basal ganglia). These neurons express abundantly the adenosine
A2A receptors that are able to stimulate production of intracellular
cAMP (Schiffmann et al., 2007). In a recent study using transgenic
mouse lines, it was estimated that about 50% of GABA MSNs
express exclusively D1Rs and 35–45% exclusively D2 receptors
(Bertran-Gonzalez et al., 2008). The population of MSNS co-
expressing both D1R and D2 receptor, is low in the dorsal striatum
and core of nucleus accumbens (about 5%) but is slightly higher
in the shell of nucleus accumbens (17%; Bertran-Gonzalez et al.,
2008; Hasbi et al., 2009; Matamales et al., 2009).
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Pharmacological studies and investigations on D1R-deleted
mice have shown the importance of D1R in mediating the effects
of DA neurotransmission (Drago et al., 1998a; El-Ghundi et al.,
2007). The actions of D1R require the participation of het-
erotrimeric guanine nucleotide binding proteins (G proteins)
whose roles in diverse signaling pathways may be determined
by their speciﬁc αβγ subunit combinations. These heterotrimeric
G proteins are molecular switches in which the agonist-activated
receptors catalyze the exchange of GDP for GTP on the α-subunit
of heterotrimeric G proteins (Gα), which in turn engages confor-
mational and/or dissociational events between the Gα and dimeric
Gβγ subunits (Bourne et al., 1991). In the case of D1R, it is well
established that theGTP-boundGα subunit initiates the activation
of adenylyl cyclase (AC) leading to the intracellular production of
cAMP and stimulation of cAMP-dependent protein kinase (PKA)
and others cAMP-dependent proteins (Kebabian and Calne, 1979;
Hervé and Girault, 2005). An extensive body of evidence indicates
that D1-type receptors also couple via Gαq subunits to phospho-
lipase C (Mahan et al., 1990; Arnt et al., 1992; Wang et al., 1995;
Lezcano and Bergson, 2002; Mannoury La Cour et al., 2007) but a
debate exists to know if the receptors involved are bona ﬁde D1Rs
(Mannoury La Cour et al., 2007), heteromers of D1R and D2
receptor (Hasbi et al., 2009), or different receptors with D1-type
pharmacological properties (Friedman et al., 1997). Here, we will
review the present knowledge about the nature of the G proteins
able to couple D1R to AC in the striatum and about the regu-
latory processes at the level of these G proteins that control the
D1R-mediated signaling and its functional consequences.
GαOLF ROLE IN THE COUPLING OF D1R AND A2A RECEPTOR
TO ADENYLYL CYCLASE IN THE STRIATUM
Since D1R is positively coupled to AC, a long-standing dogma
stated that this action was mediated by the classical heterotrimeric
stimulatory G protein containing the Gαs subunit. However, the
Gαs expression is low in the striatum compared with that observed
in many other brain areas (Figure 1A; Largent et al., 1988). In the
striatum,Gαs is replaced by a high expression of Gαolf, an isoform
of Gαs (Figure 1; Drinnan et al., 1991; Herve et al., 1993) which
was ﬁrst discovered in the olfactory epithelium and found crucial
for olfaction by mediating the coupling of olfactory receptors to
AC (Jones and Reed, 1989; Belluscio et al., 1998).
In rodents Gαolf is highly expressed in all theMSNs in the stria-
tum including those bearing theD1R (Kull et al., 2000;Herve et al.,
2001). It is also expressed in cholinergic aspiny interneurons in the
striatum. In human, high expression of Gαolf was also detected
in the striatum and its decrease in patients with Huntington’s dis-
ease is a strong indication of its expression in the MSNs (Corvol
et al., 2004). In the striatum of mice with a null targeted muta-
tion of Gαolf-encoding gene, AC activation in response to D1R
stimulation is absent, which demonstrates clearly that the D1R
acts through the Gαolf protein to stimulate cAMP production
(Zhuang et al., 2000; Corvol et al., 2001).
However, Gαolf and D1R are not systematically associated in
the various neuronal types. D1R is present in neurons that do
not express high level of Gαolf, such as the neurons of prefrontal
cortex. In these neurons, AC activation to D1 agonist is medi-
ated through Gαs as indicated by the lack of alteration of this
FIGURE 1 | Similar distribution of D1 receptor and Gαolf protein in the
striatum. (A) Distribution of Gαolf and Gαs mRNAs in rat forebrain. Gαolf
mRNA (left) is highly expressed in striatal areas, including caudate putamen
(Cp), nucleus accumbens (NA), and olfactory tubercle (OT). These areas
show almost no expression of Gαs, except for some sparse neurons (right).
On the contrary, Gαs mRNA was highly expressed in many brain areas
including all cortical areas, septum, most of the hypothalamic and thalamic
nuclei, hippocampus, and amygdala, in which Gαolf mRNA expression is
very low. In few brain regions, substantial expression of both Gαolf and Gαs
mRNAs is observed: piriform cortex (Pyr), medial habenula (Hb), and
dentate gyrus (DG). Positive of X-ray ﬁlms exposed to rat brain sections
hybridized with 35S-labeled probes for Gαolf (left) and Gαs mRNAs (right).
Scale bar, 5mm. Adapted with permission from the work of Herve et al.
(2001). (B) Mouse sections (30μm-thick) have been incubated with mouse
antibodies against D1R (generous gift of R. Luedtke) and rabbit antibodies
against Gαolf. The primary antibodies were detected with IRDye700
conjugated anti-mouse IgG and IRDye800 conjugated anti-rabbit IgG. The
sections were scanned using a LI-COR Odyssey infrared ﬂuorescent
detection system. The ﬁgure shows the scans of one representative
section with anti-D1R (upper panel) and anti-Gαolf antibodies (lower panel).
Adapted with permission from the work of E. Valjent.
response in Gαolf-deﬁcient mutant mice (Corvol et al., 2001). In
the other hand, Gαolf is present in high amount in the MSNs
without D1R expression that project to the globus pallidus and
contain D2 receptors. In these neurons, Gαolf is involved in the
positive coupling of adenosine A2A receptors with AC since an
A2A receptor agonist dose dependently activates Gαolf in striatal
membranes (Kull et al., 2000) and the stimulatory effect of this
agonist on AC activity is missing in the mutant mice deﬁcient in
Gαolf (Corvol et al., 2001).
GαOLF IS NECESSARY FOR DOPAMINE ACTION IN THE
STRIATUM
Mice homozygous for null mutation in Gαolf gene show a com-
plete anosmia because of the crucial role played by Gαolf in
the transduction of the olfactory receptor at the level of pri-
mary olfactory neurons (Belluscio et al., 1998). This profound
anosmia produces an important postnatal lethality (more than
80% of the mutant mice do not feed properly and die within
3 days after birth). The rare surviving homozygous animals exhibit
reduction in body weight and they display a marked hyperactive
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behavior, evoking a possible alteration of striatal functions (Bel-
luscio et al., 1998). The psychostimulants, such as cocaine or
d-amphetamine, produce in the striatum the activation of sev-
eral D1R-dependent signaling events, including activation of PKA,
extracellular signal-regulated kinase (ERK), or c-fos gene induc-
tion (Berretta et al., 1992; Valjent et al., 2000; Nairn et al., 2004).
All these effects are absent when Gαolf gene is deleted (Zhuang
et al., 2000; Corvol et al., 2007), showing the crucial role played
by Gαolf in most of the known intracellular effects of D1R
activation.
The D1 agonist-induced hyperlocomotor response is abolished
in Gαolf knockout mice, indicating that Gαolf is necessary for
behavior action of D1R stimulation (Zhuang et al., 2000). In addi-
tion, it is well established that the acute hyperlocomotion induced
by cocaine is dependent on D1R stimulation (Drago et al., 1998a;
Valjent et al., 2000). It is noteworthy that the acute locomotor
response to cocaine is absent in Gαolf knockout mice (Zhuang
et al., 2000). Altogether, these observations demonstrate that acute
responses to cocaine and probably other psychostimulants are
highly dependent on Gαolf-linked D1R signaling.
COMPARISON OF GαOLF AND GαS
Gαolf shares 80% amino acid identity with Gαs and the
exon/intron structures of genes encoding Gαolf and Gαs (Gnal
and Gnas respectively in mouse) are very similar, the main differ-
ence being the absence in Gnal of the alternatively spliced exon
3 of Gnas (Jones and Reed, 1989; Wadhawan et al., 2008). Both
genes are characterized by the use of alternate upstream promoters
and ﬁrst exons giving rise to “extra-large” variants of the proteins
(XL–Gαolf and XL–Gαs) in addition to the classically described
proteins (Corradi et al., 2005). XL–Gαolf, in which the N-terminal
end of Gαolf is replaced by a longer polypeptide, is able to couple
D1R to AC in transfected cells because it retains all the functional
domains of Gαolf. In the human striatal areas, the expression of
XL–Gαolf mRNA is low, about 10-fold less than that of Gαolf
mRNA (Corradi et al., 2005). In striatal extracts of rodents, the
protein is below the detection threshold in western blotting (per-
sonal observations). In the vicinity of the two alternatively used
exons, both Gnal and Gnas locus contain CpG islands that could
undergo differential methylation of DNA (Corradi et al., 2005;
Wadhawan et al., 2008). DNA methylation most often results in
repression of transcription and constitutes a hallmark of genomic
imprinting. In the gene encoding Gαs, differential methylation of
CpG islands was reported in the alleles of maternal or paternal
origins, and distinct transcripts are either biallelically expressed,
maternally imprinted, or paternally imprinted (Weinstein et al.,
2001). For instance, the XL–Gαs mRNA is a transcript speciﬁc of
the paternally derived allele (Plagge et al., 2008). It is possible that
similar phenomenon exists for XL–Gαolf mRNA but the speciﬁc
imprinting that affects the maternal and paternal alleles of Gαolf
gene has not been precisely determined (Corradi et al., 2005).
The Gnal and Gnas genes are present in all the examined ver-
tebrates, including mammals, amphibians, and ﬁshes (Wadhawan
et al., 2008). In contrast, studies in Drosophila indicate the exis-
tence only one Gnas ortholog (Wolfgang et al., 2001), suggesting
that Gnas and Gnal result from a gene duplication after the diver-
gence of vertebrates from invertebrates but before the divergence
of tetrapods from ﬁshes. The time point of this event is estimated
at −570 millions of years (Wadhawan et al., 2008).
Gαolf displays some functional differences with Gαs. Partic-
ularly, its afﬁnity for GDP is lower and its deactivation after
GTP-binding is more rapid (Liu et al., 2001). Because of these
properties,Gαolf has ahigher constitutive activity thanGαs in vitro
(Liu et al., 2001),whichmay explain the decrease of basalAC activ-
ity in the Gαolf knockout mice (Corvol et al., 2001). This relatively
high constitutive activity of Gαolf could result in a tonic AC activ-
ity in vivo leading to a constant activation of cAMP pathway in
both striatonigral and striatopallidal MSNs.
Some evidence shows also that the percentage of AC activa-
tion is higher when receptor is coupled to Gαolf than when it
is coupled to Gαs (Liu et al., 2001). Basically the signal-to-noise
ratio for Gαolf-coupled receptor appears considerably greater. In
addition, because of its ability to deactivate more rapidly, Gαolf
could give rise to more transient activation of AC than Gαs. It
is conceivable that physiological functions of dopamine in the
striatum require phasic AC activation and the fast deactivation
of Gαolf could contribute to rapidly restore responsiveness of
MSNs between two dopamine stimuli. Adenosine signaling is
generally regarded as a slow modulator regulating A2A receptor-
containing neurons in the striatum. However, evidence indicates
that the formation of extracellular adenosine partly results from
ATP released from nerve endings, which is dephosphorylated in
adenosine by ecto-nucleotidases (Fredholm et al., 2005; Schiff-
mann et al., 2007). ATP is stored in synaptic vesicles together with
most of neurotransmitters, including glutamate, and is co-released
with the neurotransmitter upon nerve stimulation. Because Gαolf
provides high signal-to-noise ratio and rapidly deactivates, the
Gαolf-dependent signaling of A2A receptor could mediate more
time-limited actions than it is generally believed and could quickly
adapt MSN functions to transient variations in synaptic input.
SPECIFIC ASSEMBLY OF GαOLF/β2/γ7 MEDIATES COUPLING
OF D1R TO ADENYLYL CYCLASE
The regional expression of the γ7 subunit of G protein (Gγ7) in
the brain was found to mirror that of D1R and Gαolf, with a par-
ticularly high expression in MSNs (Watson et al., 1994), suggesting
thatGγ7 subunit selectively associateswithGαolf to coupleD1R to
AC. In agreement with this hypothesis, the deletion of Gγ7 gene in
mutant mice causes an important reduction in the levels of Gαolf
and logically leads to drastic reduction of D1R or A2A responses
on the cAMP production (Schwindinger et al., 2003, 2010). In the
Gγ7 mutant mice, reduction of β2 subunit of G protein (Gβ2) was
also observed and quantitative measurements have indicated that
the decrease in Gγ7, Gαolf, and Gβ2 was very similar in term of
molarity, strongly suggesting a speciﬁc assembly of Gαolf/β2/γ7
heterotrimer enabling D1R coupling to AC in the striatal MSNs
(Figure 2; Schwindinger et al., 2010).
Interestingly, in the mice with targeted deletion of Gαolf gene,
the levels of Gγ7 remain normal contrasting with the selective and
coordinated reduction of Gαolf and Gβ2 observed in the mutant
mice lacking Gγ7 (Schwindinger et al., 2010). Because the corre-
sponding mRNAs are not altered, the simplest explanation is to
postulate that Gγ7 is required at a post-transcriptional level for
the stabilization and/or trafﬁcking of the Gαolf and Gβ2 proteins
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FIGURE 2 | A specific assembly of Gαolf, Gβ2, and Gγ7 subunits of G
protein mediates the coupling of D1 receptor to adenylyl cyclase 5.The
expression of Gγ7 subunit in striatal neurons recruits and stabilizes Gαolf
and Gβ2 subunits. They form a speciﬁc heterotrimeric protein that provides
the signaling complex necessary for the coupling of D1R receptor to the
adenylyl cyclase 5 (AC5), an isoform particularly enriched in the striatum.
The D1R stimulation by dopamine activates the Gαolf/β2/γ7 heterotrimer by
triggering substitution of GDP by GTP in the Gαolf subunit and changes in
the subunit conformation. The current data indicate that the Gα activation
does not necessary cause its dissociation from Gβγ complex as it was
thought previously (Bunemann et al., 2003). It has been proposed a
“clamshell” model according to which activated receptor provokes
movements in Gαβγ complex that unmask previously buried interfaces and
enable interaction of Gα and Gβγ with speciﬁc effectors (Robishaw and
Berlot, 2004). In this model, the Gβγ subunits are not shared among several
α subunits but can remain associated with a speciﬁc pool of α subunit
(Robishaw and Berlot, 2004). Such stable association may contribute to the
speciﬁcity of Gαolf interaction with Gβ2γ7 complex. In addition, the
activation of the heterotrimeric complex could increase its vulnerability to
degradation processes. This effect could explain why the receptor usage
reduces the Gαolf levels in striatal neurons.
to the plasma membrane. These results indicate that in the MSNs,
the formation of the Gαolf/β2/γ7 heterotrimer is a hierarchical
process that begins by the production of Gγ7 subunits and the
later recruitment of Gαolf and Gβ2 subunits. These observations
are surprising since MSNs express others types of γ subunits of G
proteins, sometimes in higher abundance than Gγ7. The Gγ7 sub-
unit appears to recruit selectively Gαolf and Gβ2 subunits to form
a highly specialized heterotrimeric G protein in the MSNs, refut-
ing the notion that G protein subunits are largely interchangeable
(Schwindinger et al., 2010).
Medium spiny neurons are specially enriched in type 5 AC
(AC5; Glatt and Snyder, 1993) that provides around 80% of basal
AC activity in the striatum (Lee et al., 2002; Iwamoto et al., 2003).
These observations suggest that this AC isoform is associated with
the Gαolf/β2/γ7 heterotrimeric G protein in the MSNs. In agree-
ment with this idea, the lack of AC5 in the striatum of mice
homozygous for a null mutation of AC5 gene produces drastic
decrease of Gαolf content in the striatum and AC activation in
response to D1 agonist (Lee et al., 2002; Iwamoto et al., 2004).
The mice deﬁcient in AC5 display important deﬁcit in appetitive
pavlovian conditioning (Kheirbek et al., 2008) but surprisingly
increased locomotor response to D1 agonist (Lee et al., 2002).
This paradoxical response is related to D1R stimulation since it is
blocked by D1R antagonist, but its understanding remains unclear
(Lee et al., 2002). It was hypothesized that the D1R-dependent
behavior seen in AC5 knockout mice is related to non-AC effec-
tors but the identiﬁcation of these D1R-activated signaling path-
ways remains to be determined. The ERK pathway appears to be
excluded since the AC5 knockout mice show a profound decou-
pling of D1R from downstream activation of ERK, similar to that
observed on cAMP pathway (Kheirbek et al., 2008). It remains
the possible implication of D1R coupled to phospholipase C in
the striatum (Wang et al., 1995), or D1Rs independent from AC5
expressed in extrastriatal motor regions in the brain. Alternatively,
the absence of AC5 in the striatum could produce profound alter-
ations of other signaling pathways leading to an exacerbation of
D1R-related responses despite the low D1R-related responses on
cAMP production. Particularly, the behavioral responses linked
to D2 receptors are completely eliminated in the mutant mice
(Lee et al., 2002), possibly leading to an enhancement of responses
produced by D1 agonist.
In conclusion, the signaling machinery enabling D1R to acti-
vate cAMP pathway is made up of a highly specialized assembly
of Gαolf/β2/γ7 heterotrimer and AC5. The consequences in term
of functions, response dynamics, subcellular localization, or regu-
lation remain largely unknown. Interestingly, the absence of Gγ7
or AC5 produces reduction of Gαolf levels in the striatum, most
probably by shortening its half-life. In activated state (GTP lig-
anded), Gαolf interacts with AC5 while in inactivated state, Gαolf
is associated with Gβ2γ7 complex. Gαolf stability appears thus to
depend on the cellular availability of its two main interacting mol-
ecules, suggesting the tight and coordinated regulation of Gαolf
quantity in the neuron.
GαOLF LEVELS CONTROL THE EFFICACY OF THE ADENYLYL
CYCLASE ACTIVATION BY D1R
The reductions of the levels of Gαolf or D1R have contrasting
consequences on various D1R signaling responses in the mouse
striatum. These diminutions of Gαolf or D1R can be obtained in
mice heterozygous for targeted deletions of Gαolf or D1R genes
(Drago et al., 1994; Corvol et al., 2001), in which the striatal con-
tents of corresponding proteins are decreased by about 50%. The
reduction in Gαolf levels induces a marked reduction of both
basal and D1R-activated cAMP production in striatal membranes
(Herve et al., 2001; Corvol et al., 2007). The AC activities in
the presence of dopamine or in basal condition are reduced by
approximately 50% and the D1R-related response (as estimated
by the difference between the basal and stimulated activities) by
about 35%. In contrast, the haplodeﬁciency in D1R leads to no
signiﬁcant change in D1 agonist response or in the basal and
dopamine-stimulated activities (Corvol et al., 2007).
The levels of Gαolf are not only determinant for in vitro AC
responses, but also for in vivo responses. The increased cAMP
levels resulting from D1R stimulation activate PKA in striatal neu-
rons, leading to the phosphorylation of numerous PKA substrates
including the GluR1 subunit of AMPA glutamate receptors (Val-
jent et al., 2005). Acute injection of psychostimulants like cocaine
or d-amphetamine activates this pathway by increasing extra-
cellular levels of dopamine in the brain. This response is highly
Frontiers in Neuroanatomy www.frontiersin.org August 2011 | Volume 5 | Article 48 | 4
Hervé Golf in dopamine and adenosine signaling
dependent on Gαolf in the striatum since it is strongly decreased
when the Gαolf levels are reduced in the brain (mutant mice with
heterozygous null mutation of Gαolf gene; Corvol et al., 2007).
Reduction in D1R in mice heterozygous for null mutation of D1R
gene did not alter signiﬁcantly this response.
These results show that the levels of Gαolf protein, but not
D1R, constitute a limiting factor determining the amplitude of
cAMP pathway response upon D1R activation in the striatal neu-
rons. This observation is consistent with the existence of “spare”
D1Rs not coupled to AC in the striatum (Hess et al., 1987; Trovero
et al., 1992). However, this is in apparent contradiction with the
existence of a large excess of Gαolf/β2/γ7 heterotrimers in com-
parison with D1Rs in term of number of molecules present in
striatal membranes. Thorough measurements using quantitative
immunoblots indicate that the concentration of G protein in stri-
atal membrane is around 70–80 pmol/mg of membrane protein
(Schwindinger et al., 2010). In contrast, the content in D1R (and
A2A receptors) would be almost two orders of magnitude lower
(about 1 and 0.3 pmol/mg of membrane protein for D1R and A2A
receptor, respectively; Hess et al., 1987; Schwindinger et al., 2010).
The mechanisms of activation of G proteins by receptors are still a
matter of debate. Depending on receptor/G protein systems, two
opposing models have been proposed (Lohse et al., 2008): (1) in
the“collision coupling”model, the receptor/G protein interactions
occur as a result of free lateral diffusion within the plasma mem-
brane, wherein G proteins only interact with activated receptors;
(2) the alternative model suggests that G proteins can interact
with receptors before agonist binding, in a “precoupling” state.
The second model is attractive because it could explain the speci-
ﬁcity of coupling of D1R with precise G proteins. However, in this
model, decreasing levels of receptor and G protein should lead
to similar reductions of cAMP production. “Collision coupling”
model explains probably better the mechanisms occurring in the
striatal membranes even though the kinetics data are not enough
precise to really settle this issue. In this model, the high excess
of G proteins in the MSNs in vivo can result in ampliﬁcation of
signal, activated receptors being able to switch on multiple G pro-
teins. This notion has been well established in the retina for the
rhodopsin–transducin system (similar to the receptor-G protein
couple) in which studies have given rates of 1300 transducin mol-
ecules activated per rhodopsin molecule per second (Heck and
Hofmann, 2001). Probably the ampliﬁcation factor is lower in the
striatal cells, but it is well conceivable that despite the high excess
in Gαolf/β2/γ7 heterotrimers compared to D1R (or A2A recep-
tor), partial activation of D1R can saturate the G proteins present
in the plasma membrane and thus the levels of the G proteins can
represent a limiting factor controlling the D1R coupling with AC.
PARTIAL REDUCTION OF GαOLF LEVELS DOES NOT ALTER
ERK PATHWAY
Surprisingly, the haplodeﬁciency of Gαolf gene does not affect
D1R-dependent ERK pathway in the striatal neurons, contrary
to what is observed for the cAMP pathway. Psychostimulants
(cocaine or d-amphetamine) produce ERK activation speciﬁcally
in D1R expressing striatal neurons (Valjent et al., 2000; Bertran-
Gonzalez et al., 2008). This effect is dependent on D1R activation
since it is prevented by pharmacological or genetic inaction of
D1R (Valjent et al., 2000, 2005). Importantly this pathway appears
critical for the long-lasting effects of cocaine or d-amphetamine,
including conditioned place preference and locomotor sensitiza-
tion (Valjent et al., 2000, 2006). In the heterozygous Gαolf mutant
mice, psychostimulant-induced ERK activation is normal, similar
to that observed in the wild type animals (Corvol et al., 2007).
Unexpectedly, this ERK response is impairedwhen theD1R lev-
els are reduced by half in the mice heterozygous for null mutation
of D1R gene (Pascoli et al., 2010). In the same mice cAMP/PKA
response appears completely normal. In fact, the mechanisms
of ERK activation following psychostimulants are complex since
stimulation of D1R cannot activate ERK alone but potentiates the
ERK activation initiated by calcium inﬂux through glutamate-
activated NMDA receptor (Pascoli et al., 2010). The mecha-
nisms of this potentiation are probably multiple and combine
PKA-dependent and independent processes. The cAMP/PKA-
dependent potentiation of ERKpathway ismediated by the protein
DARPP-32 via its ability to inhibit protein phosphatase 1 and
striatal-enriched tyrosine phosphatase (STEP;Valjent et al., 2005).
More recently, it has been uncovered an alternative pathway, by
which D1R can stimulate glutamate-induced ERK activation by
promoting D1R-dependent activation of Src family kinases and
tyrosine phosphorylation of the NR2B subunit of NMDA recep-
tor (Pascoli et al., 2010). This pathway is independent from the
cAMP/PKA cascade and appears to be downregulated in mice het-
erozygous for null mutation of D1R gene (Pascoli et al., 2010). In
these animals, the impairment of cocaine-induced ERK activation
goes together with reduced activation of Src family kinase and
phosphorylation of NR2B subunit.
In conclusion, D1R levels control the efﬁciency of the D1R-
regulated ERK pathway whereas Gαolf levels controls that of the
D1R-regulated cAMP/PKA pathway.
REDUCTION OF GαOLF LEVELS HAS CONTRASTED
BEHAVIORAL CONSEQUENCES
As previously mentioned, the acute responses to cocaine and d-
amphetamine are highly dependent on D1R-linked signaling. The
Gαolf heterozygous mice display a clear reduction in acute loco-
motor response to cocaine or d-amphetamine, in agreement with
the decreased cAMP signaling responses in vivo (Herve et al., 2001;
Corvol et al., 2007). By contrast a partial decrease in D1R amounts
did not signiﬁcantly affect the acute locomotor response to cocaine
ord-amphetamine inD1Rheterozygousmice (Corvol et al., 2007).
This is consistent with the unaltered biochemical responses of the
PKA pathway in these mice.
In contrast, the partial deﬁciency of Gαolf does not prevent
the development of locomotor sensitization to cocaine or d-
amphetamine in Gαolf heterozygous mice (Corvol et al., 2007).
Moreover, because the acute locomotor response is very low in
these mice, the sensitized response appears proportionally higher
than in wild type animals. Similarly, conditioned place prefer-
ence to d-amphetamine is not altered in Gαolf heterozygous
mice. The contrast between altered responses to acute adminis-
trations of psychostimulants and normal responses to repeated
treatments in these mice suggests that different signaling path-
ways may be limiting for the two types of effects. Several factors
could account for the quasi-normal sensitizing and conditioning
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properties of psychostimulants, including the possibility that these
effects are partially independent from D1R activation (Salomon
et al., 2006). One interesting possibility involves the ERK pathway
which is normally activated by psychostimulants in Gαolf het-
erozygous mice. ERK appears essential for long-lasting effects of
drugs since its pharmacological inhibition blocks both locomotor
sensitization and conditioned place preference with only minor
effects on acute responses (Valjent et al., 2000, 2006). The nor-
mal psychostimulant-induced ERK activation could enable these
responses in the Gαolf heterozygous mutant mice. Some evidence
argues in favor of this hypothesis. In particular, it has been found
some alterations of the sensitization to cocaine in mice heterozy-
gous for D1R gene, in which ERK activation, but not cAMP/PKA
activation, is altered in response to cocaine (Valjent et al., 2010).
These studies indicate that variability in the levels of expression
of speciﬁc genes involved in various aspects of D1R signaling can
produce very different behavioral reactions in response to drugs.
Depending on the element affected, genetic or environmental fac-
tors altering components of D1R signaling can have contrasted
consequences leading to speciﬁc pathological or phenotypical
traits.
REGULATION OF GαOLF LEVELS
Because Gαolf levels constitute an important parameter control-
ling D1R-dependent cAMP/PKA pathway, they could represent an
ideal target for regulation in physiological and pathological con-
ditions. Such regulations have been well demonstrated following
degeneration of dopamine neurons in the experimental context or
human pathology of Parkinson’s disease.
The dopamine denervation of the striatum produces an impor-
tant hypersensitivity of the D1R signaling that could enable the
therapeutic effects of l-DOPA in Parkinsonian patients but also
promote averse secondary effects, essentially the abnormal invol-
untary movements or dyskinesia that develop after 5–10 years of
l-DOPA treatments (Bezard et al., 2001). This hypersensitivity
affects both the cAMP/PKA and ERK pathways, since both are
highly activated by D1R agonists in the denervated striatum (Ger-
fen et al., 2002; Pavon et al., 2006; Santini et al., 2007; Westin
et al., 2007). The denervation-induced hypersensitivity happens
despite a lack of changes in the density of D1R in the striatum
(Savasta et al., 1988; Herve et al., 1989; Missale et al., 1989) or min-
imal alterations in the intracellular distribution of D1R (Berthet
et al., 2009). The most plausible mechanism is an increase in the
coupling of D1R with G protein, which has been demonstrated
in both rodents and non-human primates after dopamine den-
ervation of the striatum (Cai et al., 2002; Aubert et al., 2005).
This higher coupling is essentially linked to an increase of Gαolf
levels in the denervated striatum. In the rat, 6-hydroxydopamine-
induced lesions of dopamine neurons in adult or newborn animals
lead to an increase by about 50% of Gαolf levels in the follow-
ing weeks (Herve et al., 1993; Marcotte et al., 1994; Penit-Soria
et al., 1997). Similar increase in Gαolf levels has been observed
in 6-hydroxydopamine-lesioned mice (Alcacer et al., unpublished
data). Upregulation of Gαolf was also observed in human puta-
men in Parkinsonian patients and, interestingly, this effect was
associated with a parallel increase in Gγ7 levels (Corvol et al.,
2004). In this study, there was a correlation between the increase
inGαolf levels and the duration of disease. In addition, the patients
in whom the increase was the highest displayed intense l-DOPA-
induceddyskinesia but therewas no established causal relationship
between the two effects.
In rat, the upregulation in the Gαolf protein levels is not linked
to a parallel increase in Gαolf mRNA expression, showing that the
regulation is post-transcriptional (Herve et al., 1993).An attractive
possibility is that changes in Gαolf protein levels depend directly
from its rate of activation. This hypothesis is supported by sev-
eral studies on Gαs which is a protein very close to Gαolf. In
cell culture, various long-lasting stimulations of Gαs by receptors,
cholera toxin, or mutation induce a downregulation of Gαs at a
post-translational level, which is independent of cAMP produc-
tion and involves possibly an increased degradation rate of the
protein (McKenzie and Milligan, 1990; Levis and Bourne, 1992;
Milligan, 1993; Adie and Milligan, 1994). The chronic lack of D1R
and Gαolf stimulation in dopamine-denervated striatum could
lower the Gαolf degradation rate and lead to accumulation of the
protein. In agreement with this hypothesis, total absence of D1R
in mutant mice with targeted invalidation of D1R gene induces
important increase of Gαolf protein levels without any modiﬁca-
tion of Gαolf mRNA expression (Herve et al., 2001). Conversely,
reduced levels of Gαolf were observed in mutant mice devoid of
dopamine transporter (Herve et al., 2001), in which extracellular
concentration of dopamine is strongly increased, leading thus to a
chronic stimulation of D1R (Giros et al., 1996). Interestingly, the
lack of A2A receptors in mutant mice produces also an upregula-
tion of Gαolf protein without any changes in the levels of Gαolf
transcripts (Herve et al., 2001). Thus these results strongly suggest
a homeostatic regulation of Gαolf in vivo, in which the intensity of
Gαolf stimulation tends to reduce its levels. These variations are
reminiscent, at the level of a G protein, of the classical “denerva-
tion hypersensitivity” and “agonist-induced desensitization,” well
characterized at the level of receptors (Freedman and Lefkowitz,
1996; Bloch et al., 1999).
The mechanisms of elimination from membrane and degrada-
tion of Gαolf or Gαs are not known in detail. Upon stimulation
of receptor, Gαs was shown to internalize in a vesicle pool, corre-
sponding probably to recycling endosomes with minimal overlap
with vesicles containing receptors (Hynes et al., 2004). Recently,
Gαs was reported to be ubiquitinated and possibly degraded
through proteasome (Nagai et al., 2010). Interestingly, Ric-8B, a
protein highly expressed in the striatum (Von Dannecker et al.,
2005), inhibits the Gαs ubiquitination, and increases the Gαs pro-
tein without affecting the Gαs mRNA level (Nagai et al., 2010).
Ric-8B plays the same essential role on Gαolf and enhances the
accumulation of Gαolf at the cytoplasmic membrane (Von Dan-
necker et al., 2006). However further studies are needed to deter-
mine the precise mechanisms important for upregulation of Gαolf
following degeneration of dopamine neurons.
CONCLUSION
An assembly composed of Gαolf,Gβ2, andGγ7 of G proteinmedi-
ates the activation of AC5 by the D1R in the MSNs expressing this
receptor while the same heterotrimer provides the coupling of
adenosine A2A receptor to AC in the MSN population contain-
ing D2 receptors. The total absence of this assembly impairs all
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the biochemical and behavioral responses involving D1R. These
studies provide the proof, probably unique in the literature, that
the receptor recognizes a speciﬁc assembly of αβγ subunits of G
protein in vivo. The Gαolf stability depends on the presence of
the Gγ7 subunit and AC5 effector protein. The cellular concen-
tration of Gαolf appears thus to be regulated by the availability of
its interacting proteins. By contrast, D1R receptor exerts a nega-
tive regulation on Gαolf: more the receptor is stimulated more the
cellular Gαolf levels decrease. As important consequences of this
regulation, it was observed an increase of striatal levels of Gαolf
following degeneration of dopamine neurons in both lesioned ani-
mals and Parkinsonian patients. Gαolf upregulation is certainly a
major factor explaining the hypersensitivity of D1R-linked cAMP
signaling detected after dopamine lesion since theGαolf levels con-
trol in vivo the efﬁciency of D1Rs on AC activation. Alterations of
levels of Gαolf or its interacting proteins because of genetic or
pathological factors could play an important role in the physiol-
ogy of Parkinson’s disease as well as in the individual responses
to therapeutic drugs. In addition, because of the involvement of
dopamine signaling in several mental diseases, such as schizophre-
nia or drug addiction, dysregulation of Gαolf could contribute
to physiopathology of these diseases. The gene encoding Gαolf
(GNAL) has been investigated as a candidate gene for several
mental diseases. To date, no coding variants of Gαolf have been
tested but a strong association with schizophrenia was reported
for an intronic marker (Schwab et al., 1998). In contrast, other
genetic studies on bipolar affective disorder and unipolar depres-
sion have yielded negative results (Tsiouris et al., 1996; Berrettini
et al., 1998; Zill et al., 2002). More recently, two studies, one in
human using intronic GNAL polymorphisms (Laurin et al., 2008)
and the other using rat models (DasBanerjee et al., 2008), suggest
a possible contribution of Gαolf in the susceptibility to attention
deﬁcit/hyperactivity disorder (ADHD) in children. These studies
suggest that alterations or quantitative modiﬁcations of the com-
ponents of speciﬁc signaling machinery associated with D1R in
the striatum have the potential to affect the various behavioral
responses linked to dopamine functions in human.
ACKNOWLEDGMENTS
The author wishes to thank Dr. Emmanuel Valjent and Dr.
Catherine Le Moine for having provided immunoﬂuorescence
and in situ hybridization images as well as Jean-Antoine Girault
and Lucile Marion-Poll for their support. The work was sup-
ported by INSERM and grants from the Fondation pour la
Recherche Médical and the Agence Nationale de la Recherche
(ANR09-MNPS-014).
REFERENCES
Adie, E. J., and Milligan, G. (1994).
Agonist regulation of cellular Gs
alpha-subunit levels in neuroblas-
toma x glioma hybrid NG108-15
cells transfected to express differ-
ent levels of the human beta 2
adrenoceptor. Biochem. J. 300(Pt 3),
709–715.
Arnt, J., Hyttel, J., and Sanchez, C.
(1992). Partial and full dopamineD1
receptor agonists in mice and rats:
relation between behavioural effects
and stimulation of adenylate cyclase
activity in vitro. Eur. J. Pharmacol.
213, 259–267.
Aubert, I., Guigoni, C., Hakansson,
K., Li, Q., Dovero, S., Barthe, N.,
Bioulac, B. H., Gross, C. E., Fisone,
G., Bloch, B., and Bezard, E. (2005).
IncreasedD1dopamine receptor sig-
naling in levodopa-induceddyskine-
sia. Ann. Neurol. 57, 17–26.
Belluscio, L., Gold, G. H., Nemes, A.,
and Axel, R. (1998). Mice deﬁcient
in G(olf) are anosmic. Neuron 20,
69–81.
Berretta, S., Robertson, H. A., and
Graybiel, A. M. (1992). Dopamine
and glutamate agonists stimulate
neuron-speciﬁc expression of Fos-
like protein in the striatum. J. Neu-
rophysiol. 68, 767–777.
Berrettini,W. H.,Vuoristo, J., Ferraro, T.
N., Buono, R. J.,Wildenauer, D., and
Ala-Kokko,L. (1998).HumanG(olf)
gene polymorphisms and vulnera-
bility to bipolar disorder. Psychiatr.
Genet. 8, 235–238.
Berthet, A., Porras, G., Doudnikoff, E.,
Stark, H., Cador, M., Bezard, E.,
and Bloch, B. (2009). Pharmacolog-
ical analysis demonstrates dramatic
alteration of D1 dopamine receptor
neuronal distribution in the rat ana-
log of L-DOPA-induced dyskinesia.
J. Neurosci. 29, 4829–4835.
Bertran-Gonzalez, J., Bosch, C.,
Maroteaux, M., Matamales, M.,
Herve, D., Valjent, E., and Girault,
J. A. (2008). Opposing patterns of
signaling activation in dopamine D1
and D2 receptor-expressing striatal
neurons in response to cocaine
and haloperidol. J. Neurosci. 28,
5671–5685.
Bezard, E., Brotchie, J. M., and
Gross, C. E. (2001). Pathophysiol-
ogy of levodopa-induced dyskinesia:
potential for new therapies.Nat. Rev.
Neurosci. 2, 577–588.
Bloch, B., Dumartin, B., and Bernard,V.
(1999). In vivo regulation of intra-
neuronal trafﬁcking of G protein-
coupled receptors for neurotrans-
mitters. Trends Pharmacol. Sci. 20,
315–319.
Bourne, H. R., Sanders, D. A., and
Mccormick, F. (1991). The GTPase
superfamily: conserved structure
and molecular mechanism. Nature
349, 117–127.
Boyson, S. J., Mcgonigle, P., and Moli-
noff, P. B. (1986). Quantitative
autoradiographic localization of the
D1 and D2 subtypes of dopamine
receptors in rat brain. J. Neurosci. 6,
3177–3188.
Bunemann, M., Frank, M., and Lohse,
M. J. (2003). Gi protein activa-
tion in intact cells involves subunit
rearrangement rather than dissocia-
tion.Proc.Natl. Acad. Sci. U.S.A. 100,
16077–16082.
Cai, G., Wang, H. Y., and Fried-
man, E. (2002). Increased dopamine
receptor signaling and dopamine
receptor-G protein coupling in den-
ervated striatum. J. Pharmacol. Exp.
Ther. 302, 1105–1112.
Corradi, J. P., Ravyn, V., Robbins, A. K.,
Hagan, K. W., Peters, M. F., Bost-
wick, R., Buono, R. J., Berrettini, W.
H., and Furlong, S. T. (2005). Alter-
native transcripts and evidence of
imprinting of GNAL on 18p11.2.
Mol. Psychiatry 10, 1017–1025.
Corvol, J. C., Muriel, M. P., Valjent,
E., Feger, J., Hanoun, N., Girault,
J. A., Hirsch, E. C., and Herve,
D. (2004). Persistent increase in
olfactory type G-protein alpha sub-
unit levels may underlie D1 recep-
tor functional hypersensitivity in
Parkinson disease. J. Neurosci. 24,
7007–7014.
Corvol, J. C., Studler, J. M., Schonn,
J. S., Girault, J. A., and Herve, D.
(2001). Galpha(olf) is necessary for
coupling D1 and A2a receptors to
adenylyl cyclase in the striatum. J.
Neurochem. 76, 1585–1588.
Corvol, J. C., Valjent, E., Pascoli, V.,
Robin, A., Stipanovich, A., Luedtke,
R. R., Belluscio, L., Girault, J. A.,
and Herve, D. (2007). Quantitative
changes in Galphaolf protein levels,
but not D1 receptor, alter speciﬁcally
acute responses to psychostimu-
lants. Neuropsychopharmacology 32,
1109–1121.
DasBanerjee, T., Middleton, F. A.,
Berger, D. F., Lombardo, J. P.,
Sagvolden, T., and Faraone, S. V.
(2008). A comparison of molec-
ular alterations in environmental
and genetic rat models of ADHD:
a pilot study. Am. J. Med. Genet.
B Neuropsychiatr. Genet. 147B,
1554–1563.
Drago, J., Gerfen, C. R., Lachowicz, J.
E., Steiner, H., Hollon, T. R., Love,
P. E., Ooi, G. T., Grinberg, A., Lee,
E. J., Huang, S. P., Bartlett, P. F.,
Jose, P. A., Sibley, D. R., and West-
phal,H. (1994).Altered striatal func-
tion in a mutant mouse lacking
D1A dopamine receptors. Proc. Natl.
Acad. Sci. U.S.A. 91, 12564–12568.
Drago, J., Padungchaichot, P., Accili, D.,
and Fuchs, S. (1998a). Dopamine
receptors and dopamine transporter
in brain function and addictive
behaviors: insights from targeted
mouse mutants. Dev. Neurosci. 20,
188–203.
Drago, J., Padungchaichot, P., Wong,
J. Y., Lawrence, A. J., Mcmanus, J.
F., Sumarsono, S. H., Natoli, A. L.,
Lakso, M., Wreford, N., Westphal,
H., Kola, I., and Finkelstein, D. I.
(1998b). Targeted expression of a
toxin gene to D1 dopamine recep-
tor neurons by cre-mediated site-
speciﬁc recombination. J. Neurosci.
18, 9845–9857.
Frontiers in Neuroanatomy www.frontiersin.org August 2011 | Volume 5 | Article 48 | 7
Hervé Golf in dopamine and adenosine signaling
Drinnan, S. L., Hope, B. P., Snutch, T. P.,
andVincent, S. R. (1991). Golf in the
basal ganglia. Mol. Cell. Neurosci. 2,
66–70.
El-Ghundi, M., O’Dowd, B. F., and
George, S. R. (2007). Insights into
the role of dopamine receptor sys-
tems in learning and memory. Rev.
Neurosci. 18, 37–66.
Fredholm, B. B., Chen, J. F., Masino,
S. A., and Vaugeois, J. M. (2005).
Actions of adenosine at its receptors
in the CNS: insights from knockouts
and drugs. Annu. Rev. Pharmacol.
Toxicol. 45, 385–412.
Freedman, N. J., and Lefkowitz, R.
J. (1996). Desensitization of G
protein-coupled receptors. Recent
Prog. Horm. Res. 51, 319–351; dis-
cussion 352–313.
Friedman, E., Jin, L. Q., Cai, G. P., Hol-
lon, T. R., Drago, J., Sibley, D. R.,
and Wang, H. Y. (1997). D1-like
dopaminergic activation of phos-
phoinositide hydrolysis is indepen-
dent of D1A dopamine receptors:
evidence from D1A knockout mice.
Mol. Pharmacol. 51, 6–11.
Gerfen, C. R., Engber, T. M., Mahan, L.
C., Susel,Z.,Chase,T.N.,Monsma,F.
J. Jr., and Sibley,D. R. (1990). D1 and
D2 dopamine receptor-regulated
gene expression of striatonigral and
striatopallidal neurons. Science 250,
1429–1432.
Gerfen, C. R., Miyachi, S., Palet-
zki, R., and Brown, P. (2002). D1
dopamine receptor supersensitivity
in the dopamine-depleted striatum
results from a switch in the reg-
ulation of ERK1/2/MAP kinase. J.
Neurosci. 22, 5042–5054.
Giros, B., Jaber, M., Jones, S. R., Wight-
man, R. M., and Caron, M. G.
(1996). Hyperlocomotion and indif-
ference to cocaine and ampheta-
mine in mice lacking the dopamine
transporter. Nature 379, 606–612.
Glatt, C. E., and Snyder, S. H. (1993).
Cloning and expression of an adeny-
lyl cyclase localized to the corpus
striatum. Nature 361, 536–538.
Gong, S., Zheng, C., Doughty, M. L.,
Losos, K., Didkovsky, N., Scham-
bra, U. B., Nowak, N. J., Joyner,
A., Leblanc, G., Hatten, M. E.,
and Heintz, N. (2003). A gene
expression atlas of the central ner-
vous system based on bacterial arti-
ﬁcial chromosomes. Nature 425,
917–925.
Hasbi, A., Fan, T., Alijaniaram, M.,
Nguyen, T., Perreault, M. L.,
O’Dowd, B. F., and George, S. R.
(2009). Calcium signaling cascade
links dopamine D1-D2 receptor
heteromer to striatal BDNF pro-
duction and neuronal growth.
Proc. Natl. Acad. Sci. U.S.A. 106,
21377–21382.
Heck, M., and Hofmann, K. P.
(2001). Maximal rate and nucleotide
dependence of rhodopsin-catalyzed
transducin activation: initial rate
analysis based on a double displace-
ment mechanism. J. Biol. Chem. 276,
10000–10009.
Hervé,D., andGirault, J. A. (2005).“Sig-
nal transduction of dopamine recep-
tors,” in Handbook of Chemical Neu-
roanatomy, 21; Dopamine, eds S. B.
Dunnett, M. Bentivoglio, A. Björk-
lund, and T. Hökfelt (Amsterdam:
Elsevier Science), 109–151.
Herve, D., Le Moine, C., Corvol, J. C.,
Belluscio, L., Ledent, C., Fienberg,
A. A., Jaber, M., Studler, J. M., and
Girault, J.A. (2001).Galpha(olf) lev-
els are regulated by receptor usage
and control dopamine and adeno-
sine action in the striatum. J. Neu-
rosci. 21, 4390–4399.
Herve, D., Levi-Strauss, M., Marey-
Semper, I., Verney, C., Tassin, J.
P., Glowinski, J., and Girault, J. A.
(1993). G(olf) and Gs in rat basal
ganglia: possible involvement of
G(olf) in the coupling of dopamine
D1 receptor with adenylyl cyclase. J.
Neurosci. 13, 2237–2248.
Herve,D., Trovero, F., Blanc,G., Thierry,
A. M., Glowinski, J., and Tassin, J. P.
(1989). Nondopaminergic prefron-
tocortical efferent ﬁbers modulate
D1 receptor denervation supersen-
sitivity in speciﬁc regions of the rat
striatum. J. Neurosci. 9, 3699–3708.
Hess, E. J., Battaglia, G., Norman,
A. B., and Creese, I. (1987). Dif-
ferential modiﬁcation of striatal
D1 dopamine receptors and effec-
tormoieties byN-ethoxycarbonyl-2-
ethoxy-1,2-dihydroquinoline in vivo
and in vitro. Mol. Pharmacol. 31,
50–57.
Hynes, T. R., Mervine, S. M., Yost, E.
A., Sabo, J. L., and Berlot, C. H.
(2004). Live cell imaging of Gs
and the beta2-adrenergic receptor
demonstrates that both alphas and
beta1gamma7 internalize upon
stimulation and exhibit similar
trafﬁcking patterns that differ
from that of the beta2-adrenergic
receptor. J. Biol. Chem. 279,
44101–44112.
Iwamoto, T., Iwatsubo, K., Okumura,
S., Hashimoto, Y., Tsunematsu, T.,
Toya, Y., Herve, D., Umemura, S.,
and Ishikawa, Y. (2004). Disruption
of type 5 adenylyl cyclase negates
the developmental increase in Gal-
phaolf expression in the striatum.
FEBS Lett. 564, 153–156.
Iwamoto, T., Okumura, S., Iwatsubo,
K., Kawabe, J., Ohtsu, K., Sakai, I.,
Hashimoto, Y., Izumitani, A., Sango,
K., Ajiki, K., Toya, Y., Umemura,
S., Goshima, Y., Arai, N., Vat-
ner, S. F., and Ishikawa, Y. (2003).
Motor dysfunction in type 5 adeny-
lyl cyclase-null mice. J. Biol. Chem.
278, 16936–16940.
Jones, D. T., and Reed, R. R. (1989).
Golf: an olfactory neuron speciﬁc-
G protein involved in odorant signal
transduction. Science 244, 790–795.
Kebabian, J.W., and Calne,D. B. (1979).
Multiple receptors for dopamine.
Nature 277, 93–96.
Kheirbek, M. A., Beeler, J. A., Ishikawa,
Y., and Zhuang, X. (2008). A cAMP
pathway underlying reward predic-
tion in associative learning. J. Neu-
rosci. 28, 11401–11408.
Kull, B., Svenningsson, P., and Fred-
holm,B. B. (2000). AdenosineA(2A)
receptors are colocalized with and
activate g(olf) in rat striatum. Mol.
Pharmacol. 58, 771–777.
Largent, B. L., Jones, D. T., Reed, R. R.,
Pearson, R. C., and Snyder, S. H.
(1988). G protein mRNA mapped
in rat brain by in situ hybridiza-
tion. Proc. Natl. Acad. Sci. U.S.A. 85,
2864–2868.
Laurin, N., Ickowicz, A., Pathare, T.,
Malone, M., Tannock, R., Schachar,
R., Kennedy, J. L., and Barr, C. L.
(2008). Investigation of the G pro-
tein subunit Galphaolf gene (GNAL)
in attention deﬁcit/hyperactivity
disorder. J. Psychiatr. Res. 42,
117–124.
Le Moine, C., and Bloch, B. (1995).
D1 and D2 dopamine receptor gene
expression in the rat striatum: sen-
sitive cRNA probes demonstrate
prominent segregation of D1 and
D2 mRNAs in distinct neuronal
populations of the dorsal and ven-
tral striatum. J. Comp. Neurol. 355,
418–426.
Lee, K. W., Hong, J. H., Choi, I. Y., Che,
Y., Lee, J. K., Yang, S. D., Song, C. W.,
Kang,H. S.,Lee, J.H.,Noh, J. S., Shin,
H. S., andHan,P. L. (2002). Impaired
D2 dopamine receptor function in
mice lacking type 5 adenylyl cyclase.
J. Neurosci. 22, 7931–7940.
Lee, K. W., Kim,Y., Kim, A. M., Helmin,
K., Nairn, A. C., and Greengard,
P. (2006). Cocaine-induced den-
dritic spine formation in D1 and
D2 dopamine receptor-containing
medium spiny neurons in nucleus
accumbens. Proc. Natl. Acad. Sci.
U.S.A. 103, 3399–3404.
Levis, M. J., and Bourne, H. R. (1992).
Activation of the alpha subunit of
Gs in intact cells alters its abun-
dance, rate of degradation, and
membrane avidity. J. Cell Biol. 119,
1297–1307.
Lezcano, N., and Bergson, C. (2002).
D1/D5 dopamine receptors stimu-
late intracellular calcium release in
primary cultures of neocortical and
hippocampal neurons. J. Neurophys-
iol. 87, 2167–2175.
Liu,H.Y.,Wenzel-Seifert,K., and Seifert,
R. (2001). The olfactory G protein
G(alphaolf) possesses a lower GDP-
afﬁnity and deactivates more rapidly
than G(salphashort): consequences
for receptor-coupling and adenylyl
cyclase activation. J. Neurochem. 78,
325–338.
Lohse, M. J., Nikolaev, V. O., Hein,
P., Hoffmann, C., Vilardaga, J. P.,
and Bunemann, M. (2008). Optical
techniques to analyze real-time acti-
vation and signaling of G-protein-
coupled receptors. Trends Pharma-
col. Sci. 29, 159–165.
Mahan, L. C., Burch, R. M., Monsma, F.
J. Jr., and Sibley,D.R. (1990). Expres-
sion of striatal D1 dopamine recep-
tors coupled to inositol phosphate
production and Ca2+ mobilization
in Xenopus oocytes. Proc. Natl. Acad.
Sci. U.S.A. 87, 2196–2200.
Mannoury La Cour, C., Vidal, S.,
Pasteau, V., Cussac, D., and Millan,
M. J. (2007). Dopamine D1 recep-
tor coupling to Gs/olf and Gq in rat
striatum and cortex: a scintillation
proximity assay (SPA)/antibody-
capture characterization of ben-
zazepine agonists. Neuropharmacol-
ogy 52, 1003–1014.
Marcotte, E. R., Sullivan, R. M., and
Mishra, R. K. (1994). Striatal G-
proteins: effects of unilateral 6-
hydroxydopamine lesions. Neurosci.
Lett. 169, 195–198.
Matamales, M., Bertran-Gonzalez, J.,
Salomon,L.,Degos,B.,Deniau, J.M.,
Valjent, E., Herve, D., and Girault,
J. A. (2009). Striatal medium-sized
spiny neurons: identiﬁcation by
nuclear staining and study of neu-
ronal subpopulations in BAC trans-
genic mice. PLoS ONE 4, e4770. doi:
10.1371/journal.pone.0004770
McKenzie, F. R., and Milligan, G.
(1990). Prostaglandin E1-mediated,
cyclic AMP-independent, down-
regulation of Gs alpha in neuroblas-
toma x glioma hybrid cells. J. Biol.
Chem. 265, 17084–17093.
Milligan, G. (1993). Agonist regulation
of cellularGprotein levels anddistri-
bution: mechanisms and functional
implications. Trends Pharmacol. Sci.
14, 413–418.
Missale, C., Nash, S. R., Robinson, S.
W., Jaber, M., and Caron, M. G.
(1998). Dopamine receptors: from
structure to function. Physiol. Rev.
78, 189–225.
Missale, C., Nisoli, E., Liberini, P., Riz-
zonelli, P., Memo, M., Buonam-
ici, M., Rossi, A., and Spano, P.
(1989). Repeated reserpine admin-
istration up-regulates the transduc-
tion mechanisms of D1 receptors
without changing the density of
[3H]SCH 23390 binding. Brain Res.
483, 117–122.
Frontiers in Neuroanatomy www.frontiersin.org August 2011 | Volume 5 | Article 48 | 8
Hervé Golf in dopamine and adenosine signaling
Nagai, Y., Nishimura, A., Tago, K.,
Mizuno,N., and Itoh,H. (2010). Ric-
8B stabilizes the alpha subunit of
stimulatory G protein by inhibiting
its ubiquitination. J. Biol. Chem. 285,
11114–11120.
Nairn, A. C., Svenningsson, P., Nishi, A.,
Fisone, G., Girault, J. A., and Green-
gard, P. (2004). The role of DARPP-
32 in the actions of drugs of abuse.
Neuropharmacology 47(Suppl. 1),
14–23.
Pascoli, V., Besnard, A., Herve, D.,
Pages, C., Heck, N., Girault, J.
A., Caboche, J., and Vanhoutte,
P. (2010). Cyclic adenosine
monophosphate-independent
tyrosine phosphorylation of NR2B
mediates cocaine-induced extra-
cellular signal-regulated kinase
activation. Biol. Psychiatry 69,
218–227.
Pavon, N., Martin, A. B., Mendialdua,
A., and Moratalla, R. (2006). ERK
phosphorylation and FosB expres-
sion are associated with L-DOPA-
induced dyskinesia in hemiparkin-
sonian mice. Biol. Psychiatry 59,
64–74.
Penit-Soria, J.,Durand,C.,Besson,M. J.,
and Herve,D. (1997). Levels of stim-
ulatoryGprotein are increased in the
rat striatum after neonatal lesion of
dopamine neurons. Neuroreport 8,
829–833.
Plagge, A., Kelsey, G., and Germain-Lee,
E. L. (2008). Physiological functions
of the imprinted Gnas locus and
its protein variants Galpha(s) and
XLalpha(s) in human and mouse. J.
Endocrinol. 196, 193–214.
Robishaw, J.D., andBerlot,C.H. (2004).
Translating G protein subunit diver-
sity into functional speciﬁcity. Curr.
Opin. Cell Biol. 16, 206–209.
Salomon, L., Lanteri, C., Glowinski, J.,
and Tassin, J. P. (2006). Behavioral
sensitization to amphetamine results
from an uncoupling between nora-
drenergic and serotonergic neurons.
Proc. Natl. Acad. Sci. U.S.A. 103,
7476–7481.
Santini, E., Valjent, E., Usiello, A., Carta,
M., Borgkvist, A., Girault, J. A.,
Herve, D., Greengard, P., and Fisone,
G. (2007). Critical involvement of
cAMP/DARPP-32 and extracellular
signal-regulated protein kinase sig-
naling in L-DOPA-induced dyskine-
sia. J. Neurosci. 27, 6995–7005.
Savasta, M., Dubois, A., Benavides, J.,
and Scatton, B. (1988). Different
plasticity changes in D1 and D2
receptors in rat striatal subregions
following impairment of dopamin-
ergic transmission. Neurosci. Lett.
85, 119–124.
Schiffmann, S. N., Fisone, G., Moresco,
R.,Cunha,R.A., and Ferre, S. (2007).
Adenosine A2A receptors and basal
ganglia physiology. Prog. Neurobiol.
83, 277–292.
Schultz, W. (1998). Predictive reward
signal of dopamine neurons. J. Neu-
rophysiol. 80, 1–27.
Schwab, S. G., Hallmayer, J., Lerer, B.,
Albus, M., Borrmann, M., Honig,
S., Strauss, M., Segman, R., Lichter-
mann, D., Knapp, M., Trixler, M.,
Maier, W., and Wildenauer, D. B.
(1998). Support for a chromosome
18p locus conferring susceptibility
to functional psychoses in families
with schizophrenia, by association
and linkage analysis. Am. J. Hum.
Genet. 63, 1139–1152.
Schwindinger, W. F., Betz, K. S., Giger,
K. E., Sabol, A., Bronson, S. K., and
Robishaw, J. D. (2003). Loss of G
protein gamma 7 alters behavior and
reduces striatal alpha(olf) level and
cAMP production. J. Biol. Chem.
278, 6575–6579.
Schwindinger, W. F., Mihalcik, L. J.,
Giger, K. E., Betz, K. S., Stauf-
fer, A. M., Linden, J., Herve, D.,
and Robishaw, J. D. (2010). Adeno-
sine A2A receptor signaling and golf
assembly show a speciﬁc require-
ment for the gamma7 subtype in
the striatum. J. Biol. Chem. 285,
29787–29796.
Sibley, D. R., and Monsma, F. J.
Jr. (1992). Molecular biology of
dopamine receptors. Trends Phar-
macol. Sci. 13, 61–69.
Trovero,F.,Herve,D.,Blanc,G.,Glowin-
ski, J., and Tassin, J. P. (1992). In vivo
partial inactivation of dopamine
D1 receptors induces hypersensitiv-
ity of cortical dopamine-sensitive
adenylate cyclase: permissive role of
alpha 1-adrenergic receptors. J. Neu-
rochem. 59, 331–337.
Tsiouris, S. J., Breschel, T. S., Xu, J.,
Mcinnis, M. G., and Mcmahon, F.
J. (1996). Linkage disequilibrium
analysis of G-olf alpha (GNAL) in
bipolar affective disorder. Am. J.
Med. Genet. 67, 491–494.
Valjent, E., Bertran-Gonzalez, J., Aubier,
B., Greengard, P., Herve, D., and
Girault, J. A. (2010). Mechanisms
of locomotor sensitization to drugs
of abuse in a two-injection pro-
tocol. Neuropsychopharmacology 35,
401–415.
Valjent, E., Corvol, J. C., Pages, C.,
Besson, M. J., Maldonado, R.,
and Caboche, J. (2000). Involve-
ment of the extracellular signal-
regulated kinase cascade for cocaine-
rewarding properties. J. Neurosci. 20,
8701–8709.
Valjent, E., Corvol, J. C., Trzaskos, J.
M., Girault, J. A., and Herve, D.
(2006). Role of the ERK pathway
in psychostimulant-induced loco-
motor sensitization. BMC Neurosci.
7, 20. doi: 10.1186/1471-2202-7-20
Valjent, E., Pascoli, V., Svenningsson, P.,
Paul, S., Enslen, H., Corvol, J. C.,
Stipanovich, A., Caboche, J., Lom-
broso, P. J., Nairn, A. C., Green-
gard, P., Herve, D., and Girault, J.
A. (2005). Regulation of a protein
phosphatase cascade allows conver-
gent dopamine and glutamate sig-
nals to activate ERK in the stria-
tum.Proc.Natl.Acad. Sci.U.S.A. 102,
491–496.
Von Dannecker, L. E., Mercadante, A.
F., and Malnic, B. (2005). Ric-8B,
an olfactory putative GTP exchange
factor, ampliﬁes signal transduction
through the olfactory-speciﬁc G-
protein Galphaolf. J. Neurosci. 25,
3793–3800.
Von Dannecker, L. E., Mercadante, A.
F., and Malnic, B. (2006). Ric-8B
promotes functional expression of
odorant receptors. Proc. Natl. Acad.
Sci. U.S.A. 103, 9310–9314.
Wadhawan, S., Dickins, B., and
Nekrutenko, A. (2008). Wheels
within wheels: clues to the evolution
of the Gnas and Gnal loci. Mol. Biol.
Evol. 25, 2745–2757.
Wang,H.Y.,Undie,A. S., and Friedman,
E. (1995). Evidence for the coupling
of Gq protein to D1-like dopamine
sites in rat striatum: possible role in
dopamine-mediated inositol phos-
phate formation. Mol. Pharmacol.
48, 988–994.
Watson, J. B., Coulter, P. M. II, Mar-
gulies, J. E., De Lecea, L., Daniel-
son, P. E., Erlander, M. G., and Sut-
cliffe, J. G. (1994). G-protein gamma
7 subunit is selectively expressed
in medium-sized neurons and den-
drites of the rat neostriatum. J. Neu-
rosci. Res. 39, 108–116.
Weinstein, L. S., Yu, S., Warner, D.
R., and Liu, J. (2001). Endocrine
manifestations of stimulatory
G protein alpha-subunit muta-
tions and the role of genomic
imprinting. Endocr. Rev. 22,
675–705.
Westin, J. E., Vercammen, L., Strome,
E. M., Konradi, C., and Cenci, M.
A. (2007). Spatiotemporal pattern
of striatal ERK1/2 phosphorylation
in a rat model of L-DOPA-induced
dyskinesia and the role of dopamine
D1 receptors. Biol. Psychiatry 62,
800–810.
Wolfgang, W. J., Hoskote, A., Roberts,
I. J., Jackson, S., and Forte, M.
(2001). Genetic analysis of the
Drosophila Gs(alpha) gene. Genetics
158, 1189–1201.
Yung, K. K., Bolam, J. P., Smith, A.
D., Hersch, S. M., Ciliax, B. J., and
Levey, A. I. (1995). Immunocyto-
chemical localization of D1 and D2
dopamine receptors in the basal
ganglia of the rat: light and elec-
tron microscopy. Neuroscience 65,
709–730.
Zhuang, X., Belluscio, L., and Hen,
R. (2000). G(olf)alpha mediates
dopamine D1 receptor signaling. J.
Neurosci. 20, RC91.
Zill, P., Engel, R., Baghai, T. C.,
Zwanzger, P., Schule, C., Minov, C.,
Behrens, S., Rupprecht, R., Moller,
H. J., and Bondy, B. (2002). Analysis
of polymorphisms in the olfactory
G-protein Golf in major depression.
Psychiatr. Genet. 12, 17–22.
Conﬂict of Interest Statement: The
author declares that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 14 June 2011; paper pending
published: 27 June 2011; accepted: 20 July
2011; published online: 05 August 2011.
Citation: Hervé D (2011) Identiﬁcation
of a speciﬁc assembly of the G pro-
tein Golf as a critical and regulated
module of dopamine and adenosine-
activated cAMP pathways in the stria-
tum. Front. Neuroanat. 5:48. doi:
10.3389/fnana.2011.00048
Copyright © 2011 Hervé. This is an open-
access article subject to a non-exclusive
license between the authors and Frontiers
Media SA, which permits use, distribu-
tion and reproduction in other forums,
provided the original authors and source
are credited and other Frontiers condi-
tions are complied with.
Frontiers in Neuroanatomy www.frontiersin.org August 2011 | Volume 5 | Article 48 | 9
